SOLVE FSHD Challenges Innovators with USD$10 Million Bonus Prize to Accelerate FSHD Breakthroughs in XPRIZE Healthspan Competition
VANCOUVER, B.C., October 22, 2024 – SOLVE FSHD, a venture philanthropy organization dedicated to catalyzing innovation and overcoming barriers to accelerate new therapies for facioscapulohumeral muscular dystrophy (FSHD), is calling on innovators worldwide to compete for the USD$10 million FSHD Bonus Prize, part of the XPRIZE Healthspan Competition launched on November 29, 2023.
As part of this groundbreaking initiative, eight interim prizes of $250,000 each will be awarded to teams that achieve key competition milestones by June 2025.The $8 million grand prize will be awarded to the team that successfully completes a clinical trial demonstrating significant advancements in FSHD treatment, marking a major step toward finding a cure.
Teams interested in competing for the FSHD Bonus Prize are invited to register here and submit their qualifying entries by December 20, 2024. This challenge seeks solutions that deliver measurable improvements in muscle function and fat reduction in individuals affected by FSHD, a progressive and debilitating form of muscular dystrophy.
“We are excited to partner with XPRIZE in this ambitious effort to accelerate scientific breakthroughs for FSHD. This competition will bring together the brightest minds in medicine, technology, and science, all working toward a cure for this devastating disease,” said Eva Chin, Executive Director, SOLVE FSHD.
Register your team, learn more, and get involved at www.xprize.org/healthspan.